Medtronic plc (MDT) Stock Overview
Explore Medtronic plc’s financial performance, market position, analyst ratings, and future outlook.
Medtronic plc (MDT)
Key Financials
Key Financials
Market Cap
111.5B
P/E Ratio
21.34
EPS (TTM)
$5.53
ROE
0.11%
MDT Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Medtronic plc (NYSE: MDT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Medtronic plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MDT on the NYSE shows an RSI of 36.97, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $88.45 for the NYSE listing.
Key metrics behind Medtronic plc's NYSE-traded stock include a P/E ratio of 21.34 and a market capitalization of 111.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MDT on the NYSE.